One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1002/hon.3164_284
Copy DOI Journal: Hematological oncology |  Publication Date: Jun 1, 2023 |
Affiliation: Concord Repatriation General Hospital, University of Sydney, Australian National University, Institute of Cancer Research, Royal Marsden Hospital, Ospedale Niguarda Ca' Granda, Claude Bernard University Lyon 1, Hôpital Lyon Sud, BeiGene (China), Yonsei University, First Affiliated Hospital Zhejiang University, University of Turin, University of Modena and Reggio Emilia, North Shore Hospital, Auckland City Hospital, Levine Cancer Institute, Délégation Paris 7, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Research UK Manchester Institute, Hôpital de la Conception, Flinders Medical Centre, Beatson West of Scotland Cancer Centre, University of Perugia, Istituto Oncologico Romagnolo, University of Bologna, University Hospital Kralovske Vinohrady, Charles University, Monash University, Monash HealthLong‐term efficacy and safety of zanubrutinib (ZANU) in relapsed/refractory marginal zone lymphoma (R/R MZL): final analysis of the MAGNOLIA (BGB‐3111‐214) trial
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
